Intravitreal Dexamethasone Implant for Treatment of Sarcoidosis-Related Uveitis.

Mirinae KimSeong Ah KimWookyung ParkRae Young KimYoung-Hoon Park

Published in: Advances in therapy (2019)

Intravitreal dexamethasone implant injection is efficacious in reducing anterior chamber inflammation, vitreous haze, and cystoid macular edema in patients with sarcoidosis-related uveitis. Considering that sarcoidosis shows a chronic course of disease in a significant proportion of cases, intravitreal dexamethasone implant injection is a possible option to relieve intraocular inflammation.

Keyphrases

diabetic retinopathy
age related macular degeneration
vascular endothelial growth factor
high dose
low dose
oxidative stress
soft tissue
juvenile idiopathic arthritis
ankylosing spondylitis
optical coherence tomography
rheumatoid arthritis
cataract surgery
drug induced
disease activity